nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—ABCB1—peripheral nervous system neoplasm	0.407	1	CbGaD
Rivaroxaban—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0662	0.165	CbGbCtD
Rivaroxaban—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0464	0.115	CbGbCtD
Rivaroxaban—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0464	0.115	CbGbCtD
Rivaroxaban—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0321	0.08	CbGbCtD
Rivaroxaban—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0304	0.0757	CbGbCtD
Rivaroxaban—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0279	0.0693	CbGbCtD
Rivaroxaban—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0278	0.0691	CbGbCtD
Rivaroxaban—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0258	0.0643	CbGbCtD
Rivaroxaban—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0198	0.0493	CbGbCtD
Rivaroxaban—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0185	0.0459	CbGbCtD
Rivaroxaban—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0181	0.0451	CbGbCtD
Rivaroxaban—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0124	0.0308	CbGbCtD
Rivaroxaban—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0119	0.0295	CbGbCtD
Rivaroxaban—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0109	0.027	CbGbCtD
Rivaroxaban—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00741	0.0184	CbGbCtD
Rivaroxaban—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.0002	0.00105	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.0002	0.00105	CcSEcCtD
Rivaroxaban—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000199	0.00104	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000199	0.00104	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000199	0.00104	CcSEcCtD
Rivaroxaban—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000198	0.00104	CcSEcCtD
Rivaroxaban—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000198	0.00104	CcSEcCtD
Rivaroxaban—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000198	0.00104	CcSEcCtD
Rivaroxaban—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000197	0.00103	CcSEcCtD
Rivaroxaban—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000197	0.00103	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000195	0.00102	CcSEcCtD
Rivaroxaban—Malaise—Etoposide—peripheral nervous system neoplasm	0.000194	0.00102	CcSEcCtD
Rivaroxaban—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000194	0.00102	CcSEcCtD
Rivaroxaban—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.00102	CcSEcCtD
Rivaroxaban—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000193	0.00101	CcSEcCtD
Rivaroxaban—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000193	0.00101	CcSEcCtD
Rivaroxaban—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000192	0.00101	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000192	0.00101	CcSEcCtD
Rivaroxaban—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000192	0.00101	CcSEcCtD
Rivaroxaban—Infection—Cisplatin—peripheral nervous system neoplasm	0.000191	0.000999	CcSEcCtD
Rivaroxaban—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000191	0.000999	CcSEcCtD
Rivaroxaban—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00019	0.000993	CcSEcCtD
Rivaroxaban—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000189	0.000991	CcSEcCtD
Rivaroxaban—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000189	0.000991	CcSEcCtD
Rivaroxaban—Rash—Topotecan—peripheral nervous system neoplasm	0.000189	0.00099	CcSEcCtD
Rivaroxaban—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000189	0.000989	CcSEcCtD
Rivaroxaban—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000188	0.000987	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000985	CcSEcCtD
Rivaroxaban—Headache—Topotecan—peripheral nervous system neoplasm	0.000188	0.000984	CcSEcCtD
Rivaroxaban—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000188	0.000982	CcSEcCtD
Rivaroxaban—Rash—Tretinoin—peripheral nervous system neoplasm	0.000188	0.000982	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000188	0.000982	CcSEcCtD
Rivaroxaban—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000187	0.000982	CcSEcCtD
Rivaroxaban—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000187	0.000981	CcSEcCtD
Rivaroxaban—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000187	0.000981	CcSEcCtD
Rivaroxaban—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000187	0.000981	CcSEcCtD
Rivaroxaban—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000187	0.000978	CcSEcCtD
Rivaroxaban—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000187	0.000977	CcSEcCtD
Rivaroxaban—Headache—Tretinoin—peripheral nervous system neoplasm	0.000186	0.000976	CcSEcCtD
Rivaroxaban—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000186	0.000976	CcSEcCtD
Rivaroxaban—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.000973	CcSEcCtD
Rivaroxaban—Pain—Vincristine—peripheral nervous system neoplasm	0.000186	0.000973	CcSEcCtD
Rivaroxaban—Constipation—Vincristine—peripheral nervous system neoplasm	0.000186	0.000973	CcSEcCtD
Rivaroxaban—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000973	CcSEcCtD
Rivaroxaban—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000973	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000973	CcSEcCtD
Rivaroxaban—Rash—Melphalan—peripheral nervous system neoplasm	0.000185	0.00097	CcSEcCtD
Rivaroxaban—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000185	0.000969	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000184	0.000966	CcSEcCtD
Rivaroxaban—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000184	0.000961	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000183	0.00096	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000182	0.000955	CcSEcCtD
Rivaroxaban—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000181	0.00095	CcSEcCtD
Rivaroxaban—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00018	0.00094	CcSEcCtD
Rivaroxaban—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000179	0.000938	CcSEcCtD
Rivaroxaban—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000179	0.000938	CcSEcCtD
Rivaroxaban—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000178	0.000933	CcSEcCtD
Rivaroxaban—Nausea—Topotecan—peripheral nervous system neoplasm	0.000178	0.000933	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000178	0.00093	CcSEcCtD
Rivaroxaban—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000177	0.000925	CcSEcCtD
Rivaroxaban—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000177	0.000925	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000176	0.000922	CcSEcCtD
Rivaroxaban—Infection—Etoposide—peripheral nervous system neoplasm	0.000175	0.000916	CcSEcCtD
Rivaroxaban—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000174	0.000914	CcSEcCtD
Rivaroxaban—Nausea—Melphalan—peripheral nervous system neoplasm	0.000174	0.000913	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000911	CcSEcCtD
Rivaroxaban—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000172	0.0009	CcSEcCtD
Rivaroxaban—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000172	0.000899	CcSEcCtD
Rivaroxaban—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000171	0.000897	CcSEcCtD
Rivaroxaban—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000171	0.000895	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000888	CcSEcCtD
Rivaroxaban—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000885	CcSEcCtD
Rivaroxaban—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000166	0.000871	CcSEcCtD
Rivaroxaban—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000166	0.00087	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000166	0.000869	CcSEcCtD
Rivaroxaban—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000164	0.000861	CcSEcCtD
Rivaroxaban—Pain—Cisplatin—peripheral nervous system neoplasm	0.000164	0.00086	CcSEcCtD
Rivaroxaban—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000162	0.000847	CcSEcCtD
Rivaroxaban—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00016	0.000838	CcSEcCtD
Rivaroxaban—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00016	0.000835	CcSEcCtD
Rivaroxaban—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000158	0.000829	CcSEcCtD
Rivaroxaban—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000157	0.000822	CcSEcCtD
Rivaroxaban—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000819	CcSEcCtD
Rivaroxaban—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000156	0.000816	CcSEcCtD
Rivaroxaban—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00081	CcSEcCtD
Rivaroxaban—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00081	CcSEcCtD
Rivaroxaban—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000155	0.00081	CcSEcCtD
Rivaroxaban—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000154	0.000808	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000803	CcSEcCtD
Rivaroxaban—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000153	0.000803	CcSEcCtD
Rivaroxaban—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000796	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000152	0.000796	CcSEcCtD
Rivaroxaban—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000152	0.000795	CcSEcCtD
Rivaroxaban—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00079	CcSEcCtD
Rivaroxaban—Pain—Etoposide—peripheral nervous system neoplasm	0.00015	0.000788	CcSEcCtD
Rivaroxaban—Constipation—Etoposide—peripheral nervous system neoplasm	0.00015	0.000788	CcSEcCtD
Rivaroxaban—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000787	CcSEcCtD
Rivaroxaban—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000149	0.000781	CcSEcCtD
Rivaroxaban—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000149	0.000778	CcSEcCtD
Rivaroxaban—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000772	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000766	CcSEcCtD
Rivaroxaban—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000764	CcSEcCtD
Rivaroxaban—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000145	0.00076	CcSEcCtD
Rivaroxaban—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000145	0.00076	CcSEcCtD
Rivaroxaban—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000144	0.000756	CcSEcCtD
Rivaroxaban—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000756	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000144	0.000754	CcSEcCtD
Rivaroxaban—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000144	0.000752	CcSEcCtD
Rivaroxaban—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000143	0.000751	CcSEcCtD
Rivaroxaban—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.00075	CcSEcCtD
Rivaroxaban—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.00075	CcSEcCtD
Rivaroxaban—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000142	0.000744	CcSEcCtD
Rivaroxaban—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000142	0.000744	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000743	CcSEcCtD
Rivaroxaban—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000142	0.000741	CcSEcCtD
Rivaroxaban—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.00074	CcSEcCtD
Rivaroxaban—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000737	CcSEcCtD
Rivaroxaban—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00014	0.000732	CcSEcCtD
Rivaroxaban—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000731	CcSEcCtD
Rivaroxaban—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000731	CcSEcCtD
Rivaroxaban—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000139	0.000729	CcSEcCtD
Rivaroxaban—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000729	CcSEcCtD
Rivaroxaban—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000727	CcSEcCtD
Rivaroxaban—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000727	CcSEcCtD
Rivaroxaban—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000138	0.000723	CcSEcCtD
Rivaroxaban—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000138	0.000722	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000718	CcSEcCtD
Rivaroxaban—Rash—Vincristine—peripheral nervous system neoplasm	0.000137	0.000717	CcSEcCtD
Rivaroxaban—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000137	0.000717	CcSEcCtD
Rivaroxaban—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000715	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000715	CcSEcCtD
Rivaroxaban—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000713	CcSEcCtD
Rivaroxaban—Headache—Vincristine—peripheral nervous system neoplasm	0.000136	0.000713	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000709	CcSEcCtD
Rivaroxaban—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000707	CcSEcCtD
Rivaroxaban—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000703	CcSEcCtD
Rivaroxaban—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000134	0.000701	CcSEcCtD
Rivaroxaban—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000699	CcSEcCtD
Rivaroxaban—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000131	0.000688	CcSEcCtD
Rivaroxaban—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000688	CcSEcCtD
Rivaroxaban—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00013	0.00068	CcSEcCtD
Rivaroxaban—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00013	0.000679	CcSEcCtD
Rivaroxaban—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000676	CcSEcCtD
Rivaroxaban—Nausea—Vincristine—peripheral nervous system neoplasm	0.000129	0.000676	CcSEcCtD
Rivaroxaban—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000675	CcSEcCtD
Rivaroxaban—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000673	CcSEcCtD
Rivaroxaban—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000673	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000664	CcSEcCtD
Rivaroxaban—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000126	0.000661	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000661	CcSEcCtD
Rivaroxaban—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000126	0.00066	CcSEcCtD
Rivaroxaban—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00066	CcSEcCtD
Rivaroxaban—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000657	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000655	CcSEcCtD
Rivaroxaban—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000125	0.000652	CcSEcCtD
Rivaroxaban—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000122	0.00064	CcSEcCtD
Rivaroxaban—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000636	CcSEcCtD
Rivaroxaban—Rash—Cisplatin—peripheral nervous system neoplasm	0.000121	0.000634	CcSEcCtD
Rivaroxaban—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000121	0.000634	CcSEcCtD
Rivaroxaban—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00012	0.000631	CcSEcCtD
Rivaroxaban—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000629	CcSEcCtD
Rivaroxaban—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000624	CcSEcCtD
Rivaroxaban—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000612	CcSEcCtD
Rivaroxaban—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00061	CcSEcCtD
Rivaroxaban—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000116	0.000609	CcSEcCtD
Rivaroxaban—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000609	CcSEcCtD
Rivaroxaban—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000608	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000606	CcSEcCtD
Rivaroxaban—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000598	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000587	CcSEcCtD
Rivaroxaban—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000112	0.000586	CcSEcCtD
Rivaroxaban—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000585	CcSEcCtD
Rivaroxaban—Rash—Etoposide—peripheral nervous system neoplasm	0.000111	0.000581	CcSEcCtD
Rivaroxaban—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000111	0.000581	CcSEcCtD
Rivaroxaban—Headache—Etoposide—peripheral nervous system neoplasm	0.00011	0.000577	CcSEcCtD
Rivaroxaban—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000571	CcSEcCtD
Rivaroxaban—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000568	CcSEcCtD
Rivaroxaban—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000567	CcSEcCtD
Rivaroxaban—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000563	CcSEcCtD
Rivaroxaban—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000556	CcSEcCtD
Rivaroxaban—Nausea—Etoposide—peripheral nervous system neoplasm	0.000105	0.000547	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000543	CcSEcCtD
Rivaroxaban—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000541	CcSEcCtD
Rivaroxaban—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000539	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000535	CcSEcCtD
Rivaroxaban—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000532	CcSEcCtD
Rivaroxaban—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000528	CcSEcCtD
Rivaroxaban—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000527	CcSEcCtD
Rivaroxaban—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000525	CcSEcCtD
Rivaroxaban—Oedema—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.000517	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.000517	CcSEcCtD
Rivaroxaban—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	9.83e-05	0.000515	CcSEcCtD
Rivaroxaban—Infection—Epirubicin—peripheral nervous system neoplasm	9.8e-05	0.000513	CcSEcCtD
Rivaroxaban—Shock—Epirubicin—peripheral nervous system neoplasm	9.71e-05	0.000508	CcSEcCtD
Rivaroxaban—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	9.67e-05	0.000507	CcSEcCtD
Rivaroxaban—Tachycardia—Epirubicin—peripheral nervous system neoplasm	9.63e-05	0.000504	CcSEcCtD
Rivaroxaban—Skin disorder—Epirubicin—peripheral nervous system neoplasm	9.58e-05	0.000502	CcSEcCtD
Rivaroxaban—Chest pain—Doxorubicin—peripheral nervous system neoplasm	9.52e-05	0.000499	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	9.46e-05	0.000495	CcSEcCtD
Rivaroxaban—Discomfort—Doxorubicin—peripheral nervous system neoplasm	9.41e-05	0.000493	CcSEcCtD
Rivaroxaban—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	9.31e-05	0.000488	CcSEcCtD
Rivaroxaban—Hypotension—Epirubicin—peripheral nervous system neoplasm	9.22e-05	0.000483	CcSEcCtD
Rivaroxaban—Oedema—Doxorubicin—peripheral nervous system neoplasm	9.13e-05	0.000478	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	9.13e-05	0.000478	CcSEcCtD
Rivaroxaban—Infection—Doxorubicin—peripheral nervous system neoplasm	9.07e-05	0.000475	CcSEcCtD
Rivaroxaban—Shock—Doxorubicin—peripheral nervous system neoplasm	8.98e-05	0.00047	CcSEcCtD
Rivaroxaban—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	8.95e-05	0.000469	CcSEcCtD
Rivaroxaban—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	8.91e-05	0.000467	CcSEcCtD
Rivaroxaban—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	8.87e-05	0.000464	CcSEcCtD
Rivaroxaban—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.79e-05	0.000461	CcSEcCtD
Rivaroxaban—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.000455	CcSEcCtD
Rivaroxaban—Hypotension—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	0.000447	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.52e-05	0.000446	CcSEcCtD
Rivaroxaban—Fatigue—Epirubicin—peripheral nervous system neoplasm	8.51e-05	0.000445	CcSEcCtD
Rivaroxaban—Pain—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000442	CcSEcCtD
Rivaroxaban—Constipation—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000442	CcSEcCtD
Rivaroxaban—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	8.14e-05	0.000426	CcSEcCtD
Rivaroxaban—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000426	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.000422	CcSEcCtD
Rivaroxaban—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.000421	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.88e-05	0.000413	CcSEcCtD
Rivaroxaban—Fatigue—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000412	CcSEcCtD
Rivaroxaban—Urticaria—Epirubicin—peripheral nervous system neoplasm	7.84e-05	0.00041	CcSEcCtD
Rivaroxaban—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000409	CcSEcCtD
Rivaroxaban—Pain—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000409	CcSEcCtD
Rivaroxaban—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.8e-05	0.000408	CcSEcCtD
Rivaroxaban—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000394	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.46e-05	0.000391	CcSEcCtD
Rivaroxaban—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.27e-05	0.000381	CcSEcCtD
Rivaroxaban—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.25e-05	0.00038	CcSEcCtD
Rivaroxaban—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.22e-05	0.000378	CcSEcCtD
Rivaroxaban—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.08e-05	0.000371	CcSEcCtD
Rivaroxaban—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.98e-05	0.000366	CcSEcCtD
Rivaroxaban—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000353	CcSEcCtD
Rivaroxaban—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.73e-05	0.000352	CcSEcCtD
Rivaroxaban—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.55e-05	0.000343	CcSEcCtD
Rivaroxaban—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.52e-05	0.000342	CcSEcCtD
Rivaroxaban—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.46e-05	0.000338	CcSEcCtD
Rivaroxaban—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.27e-05	0.000328	CcSEcCtD
Rivaroxaban—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.000327	CcSEcCtD
Rivaroxaban—Rash—Epirubicin—peripheral nervous system neoplasm	6.22e-05	0.000326	CcSEcCtD
Rivaroxaban—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.21e-05	0.000325	CcSEcCtD
Rivaroxaban—Headache—Epirubicin—peripheral nervous system neoplasm	6.18e-05	0.000324	CcSEcCtD
Rivaroxaban—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.04e-05	0.000316	CcSEcCtD
Rivaroxaban—Nausea—Epirubicin—peripheral nervous system neoplasm	5.86e-05	0.000307	CcSEcCtD
Rivaroxaban—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.8e-05	0.000304	CcSEcCtD
Rivaroxaban—Rash—Doxorubicin—peripheral nervous system neoplasm	5.76e-05	0.000301	CcSEcCtD
Rivaroxaban—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.75e-05	0.000301	CcSEcCtD
Rivaroxaban—Headache—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000299	CcSEcCtD
Rivaroxaban—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.42e-05	0.000284	CcSEcCtD
